Medicine

For nearly three decades, interim senior vice dean and chief scientific officer of the Perelman School of Medicine Michael Ostap has investigated how molecules such as myosin feel force, in an effort to understand how cellular mutations cause disease.

A new report from researchers at the Perelman School of Medicine and Crescenz VA Medical Center has evaluated a genetic test for opioid use disorder that recently received pre-marketing approval by the FDA, finding that the genes comprising it do not accurately identify individuals likely to develop the disorder.

Penn Medicine researchers have developed tumor-homing nanosized particles that trigger cancer cell self-destruction in preclinical tests.

The University’s nexus for technology transfer supports researchers in their innovative efforts, from CAR T to mRNA advancements that have dramatically reshaped the world.

New research from Penn Medicine finds patterns in cells of tumors may guide personalized therapies for clear cell renal cell carcinoma.

New research from Penn Medicine has uncovered the catalyst that creates a compound in fungi whose derivatives are applied to treatments for cancer and inflammation.

A team at Penn Medicine has created a resource to help inform reproductive counseling for cancer gene mutation carriers.

At the Penn Center for Neuroaesthetics, researchers explore what exactly the brain is doing when it experiences art, and what artists are doing when they create art out of their experiences.

Revisit some of the stories that highlighted the events, breakthroughs, people, and research across the University this year.